Structural Insights into Angiotensin Receptor Signaling Modulation by Balanced and Biased Agonists.

Dongqi Zhang,Yongfeng Liu,Saheem A. Zaidi,Lingyi Xu,Yuting Zhan,Anqi Chen,Jiangtao Guo,Xi-Ping Huang,Bryan L. Roth,Vsevolod Katritch,Vadim Cherezov,Haitao Zhang
DOI: https://doi.org/10.15252/embj.2022112940
2023-01-01
Abstract:The peptide hormone angiotensin II regulates blood pressure mainly through the type 1 angiotensin II receptor AT(1)R and its downstream signaling proteins G(q) and beta-arrestin. AT(1)R blockers, clinically used as antihypertensive drugs, inhibit both signaling pathways, whereas AT(1)R beta-arrestin-biased agonists have shown great potential for the treatment of acute heart failure. Here, we present a cryo-electron microscopy (cryo-EM) structure of the human AT(1)R in complex with a balanced agonist, Sar(1)-AngII, and G(q) protein at 2.9 angstrom resolution. This structure, together with extensive functional assays and computational modeling, reveals the molecular mechanisms for AT(1)R signaling modulation and suggests that a major hydrogen bond network (MHN) inside the receptor serves as a key regulator of AT(1)R signal transduction from the ligand-binding pocket to both G(q) and beta-arrestin pathways. Specifically, we found that the MHN mutations N111(3.35)A and N294(7.45)A induce biased signaling to G(q) and beta-arrestin, respectively. These insights should facilitate AT(1)R structure-based drug discovery for the treatment of cardiovascular diseases.
What problem does this paper attempt to address?